Deciphering the combination mechanisms of Gualou-Xiebai herb pair against atherosclerosis by network pharmacology and HPLC-Q-TOF-MS technology

被引:11
|
作者
Liu, Yarong [1 ,2 ]
Zhong, Hua [1 ]
Xu, Pengbo [1 ]
Zhou, An [2 ,3 ]
Ding, Lidan [1 ]
Qiu, Jingwen [1 ]
Wu, Hongfei [1 ,2 ]
Dai, Min [1 ,2 ]
机构
[1] Anhui Univ Chinese Med, Sch Pharm, Hefei, Peoples R China
[2] Anhui Prov Key Lab Res & Dev Chinese Med, Hefei, Peoples R China
[3] Anhui Univ Chinese Med, Expt Res Ctr, Hefei, Peoples R China
基金
中国国家自然科学基金;
关键词
Gualou-Xiebai; herb pair; combination mechanisms; atherosclerosis; network pharmacology; DECOCTION;
D O I
10.3389/fphar.2022.941400
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Gualou (Trichosanthes kirilowii Maxim)-Xiebai (Allium macrostemon Bunge) (GLXB) is a well-known herb pair against atherosclerosis (AS). However, the combination mechanisms of GLXB herb pair against AS remain unclear. Objective: To compare the difference in efficacy between GLXB herb pair and the single herbs and to explore the combination mechanisms of GLXB against AS in terms of compounds, targets, and signaling pathways. Methods: The combined effects of GLXB were evaluated in AS mice. The main compounds of GLXB were identified via quadrupole time-of-flight tandem mass spectrometry (UPLC-Q-TOF-MS) and UNIFI informatics platforms. The united mechanisms of GLXB in terms of nodes, key interactions, and functional clusters were realized by network pharmacology. At last, the anti-atherosclerotic mechanisms of GLXB were validated using enzyme-linked immunosorbent assay (ELISA) and Western blot in AS mice. Results: The anti-atherosclerotic effects of the GLXB herb pair (6 g/kg) were more significant than those of Gualou (4 g/kg) and Xiebai (2 g/kg) alone. From the GLXB herb pair, 48 main components were identified. In addition, the GLXB herb pair handled more anti-atherosclerotic targets and more signaling pathways than Gualou or Xiebai alone, whereas 10 key targets of GLXB were found using topological analysis. Furthermore, the GLXB herb pair (6 g/kg) could suppress the inflammatory target levels of IL-6, IL-1 beta, TNF-alpha, ALOX5, PTGS2, and p-p38 in AS mice. GLXB herb pair (6 g/kg) could also ameliorate endothelial growth and function by regulating the levels of VEGFA, eNOS, p-AKT, VCAM-1, and ICAM-1 and reducing macrophage adhesion to vascular wall in AS mice. GLXB herb pair (6 g/kg) could improve the blood lipid levels in AS mice. In addition, the regulating effects of GLXB herb pair (6 g/kg) on levels of IL-1 beta, TNF-alpha, ALOX5, VEGFA, eNOS, VCAM-1, ICAM-1, and blood lipids were more significant than those of Gualou (4 g/kg) or Xiebai alone (2 g/kg). Conclusion: The combination mechanisms of the GLXB herb pair were elucidated in terms of components, targets, and signaling pathways, which may be related to suppressing inflammation, regulating vascular endothelial growth/function, and improving blood lipid levels.
引用
收藏
页数:19
相关论文
共 16 条
  • [1] A UHPLC-Q-TOF-MS-based serum and urine metabolomics approach reveals the mechanism of Gualou-Xiebai herb pair intervention against atherosclerosis process in ApoE-/- mice
    Wang, Yuting
    Sun, Xin
    Qiu, Jingwen
    Zhou, An
    Xu, Pengbo
    Liu, Yarong
    Wu, Hongfei
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2023, 1215
  • [2] HPLC-Q-TOF-MS/MS for analysis of major chemical constituents of Yinchen-Zhizi herb pair extract
    Fu, Zhiwen
    Ling, Yun
    Li, Zhixiong
    Chen, Mingcang
    Sun, Zhaolin
    Huang, Chenggang
    BIOMEDICAL CHROMATOGRAPHY, 2014, 28 (04) : 475 - 485
  • [3] Study of Active Phytochemicals and Mechanisms of Cnidii Fructus in Treating Osteoporosis Based on HPLC-Q-TOF-MS/MS and Network Pharmacology
    Xu, Yincong
    Zhang, Shuai
    Yuan, Shinong
    Su, Yanlei
    Jia, Yuqian
    Zhang, Yajing
    Duan, Xuhong
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2024, 27 (02) : 317 - 334
  • [4] Combination of HPLC-Q-TOF-MS/MS, Network Pharmacology, and Molecular Docking to Reveal the Mechanism of Apple Pollen in the Treatment of Type 2 Diabetes Mellitus
    Wang, Yiwen
    Chen, Ping
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [5] Study of the active ingredients and mechanism of Sparganii rhizoma in gastric cancer based on HPLC-Q-TOF-MS/MS and network pharmacology
    Lu, Xiaona
    Zheng, Yawei
    Wen, Fang
    Huang, Wenjie
    Chen, Xiaoxue
    Ruan, Shuai
    Gu, Suping
    Hu, Yue
    Teng, Yuhao
    Shu, Peng
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [6] Gualou-Xiebai herb pair and its active ingredients act against atherosclerosis by suppressing VSMC-derived foam cell formation via regulating P2RY12-mediated lipophagy
    Bao, Youli
    Zhu, Li
    Wang, Yuting
    Liu, Jiahui
    Liu, Zijian
    Li, Zhenglong
    Zhou, An
    Wu, Hongfei
    PHYTOMEDICINE, 2024, 128
  • [7] Potential mechanism of action of Ixeris sonchifolia extract injection against cardiovascular diseases revealed by combination of HPLC-Q-TOF-MS, virtual screening and systems pharmacology approach
    Xie, Rongfang
    Liu, Zhenzhen
    Lin, Zuan
    Shi, Peiying
    Chen, Bing
    Li, Shaoguang
    Li, Guangwen
    Huang, Liying
    Lin, Xinhua
    Yao, Hong
    RSC ADVANCES, 2020, 10 (63) : 38497 - 38504
  • [8] The potential mechanism of Choulingdan mixture in improving acute lung injury based on HPLC-Q-TOF-MS, network pharmacology and in vivo experiments
    Wang, Lili
    Li, Zhengyan
    Lu, Tulin
    Su, Lianlin
    Mao, Chunqin
    Zhang, Yiting
    Zhang, Xinrui
    Jiang, Xiaofeng
    Xie, Hui
    Yu, Xiaoling
    BIOMEDICAL CHROMATOGRAPHY, 2023, 37 (10)
  • [9] Effects and mechanisms of Zhizi Chuanxiong herb pair against atherosclerosis: an integration of network pharmacology, molecular docking, and experimental validation
    Zhang, Yan
    Qi, Yifei
    Jia, Zijun
    Li, Yiming
    Wu, Liqi
    Zhou, Qingbing
    Xu, Fengqin
    CHINESE MEDICINE, 2024, 19 (01)
  • [10] Effects and mechanisms of Zhizi Chuanxiong herb pair against atherosclerosis: an integration of network pharmacology, molecular docking, and experimental validation
    Yan Zhang
    Yifei Qi
    Zijun Jia
    Yiming Li
    Liqi Wu
    Qingbing Zhou
    Fengqin Xu
    Chinese Medicine, 19